NPI: 1740244961 · RICHMOND, VA 23223 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/14/2006
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 04/14/2006 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 24,293 | $183K |
| 2019 | 19,823 | $203K |
| 2020 | 15,295 | $323K |
| 2021 | 8,380 | $135K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 18,761 | 1,160 | $799K |
| A4657 | Syringe, with or without needle, each | 3,013 | 960 | $23K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 23,241 | 929 | $12K |
| J1756 | Injection, iron sucrose, 1 mg | 4,604 | 780 | $4K |
| J1270 | Injection, doxercalciferol, 1 mcg | 12,873 | 845 | $2K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 335 | 80 | $2K |
| G0008 | Administration of influenza virus vaccine | 17 | 12 | $313.36 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 105 | 49 | $113.53 |
| 83970 | 947 | 498 | $96.68 | |
| 90674 | 17 | 12 | $48.08 | |
| 82728 | 405 | 231 | $24.55 | |
| 83550 | 463 | 266 | $16.53 | |
| 82108 | 319 | 182 | $12.88 | |
| 83540 | 461 | 265 | $12.23 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 58 | 27 | $11.62 |
| 85041 | 1,080 | 623 | $7.19 | |
| 85048 | 1,092 | 627 | $5.81 |